MINT-QUETIAPINE XR
MINT PHARMACEUTICALS INC
Quick answers
Is there a shortage of MINT-QUETIAPINE XR in Canada?
No. There is no current shortage of MINT-QUETIAPINE XR 50MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Why Psychiatric Medications Keep Going Into Shortage in Canada
Why antidepressants and antipsychotics like buspirone, quetiapine, escitalopram, venlafaxine, and paroxetine show up in Canadian shortage reports so often, and what to do if yours is affected.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Closest Matches
SEROQUEL XR
Extended-ReleaseCHEPLAPHARM ARZNEIMITTEL GMBH
Other Products
SEROQUEL
CHEPLAPHARM ARZNEIMITTEL GMBH
SANDOZ QUETIAPINE XRT
SANDOZ CANADA INCORPORATED
QUETIAPINE
SIVEM PHARMACEUTICALS ULC
PMS-QUETIAPINE
PHARMASCIENCE INC
PRO-QUETIAPINE
PRO DOC LIMITEE
DIN
02522187
Strength
50MG
Dosage Form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage History
Other Products from MINT PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
300MG · DIN 02480956
10MG · DIN 02468840
25MG · DIN 02468859
200MG · DIN 02524708
400MG · DIN 02524716
800MG · DIN 02524724
70.0MG · DIN 02394871
5MG · DIN 02362651
10MG · DIN 02362678
1MG · DIN 02393573
5MG · DIN 02495449
2.5MG · DIN 02495430